康臣药业集团有限公司（股票代码：01681）于2026年9月17日公告回购公司股份，共计回购股份50,000股，占当日现有已发行股本约0.006%。此次回购的每股价格介乎每股13.09港元至13.15港元，总成交额约65.53万港元。回购股份将列作公司库藏股。
回购完成后，公司已发行股本总数增至841,589,615股，其中837,836,615股为已发行股份（不包括库藏股），库藏股股份数增至3,753,000股。公告显示，本次回购基于公司于2026年5月26日通过的购回授权，公司可在授权额度84,120,311股内进行回购。截至目前，公司已根据该授权累计回购3,409,000股，占授权通过当日已发行股本约4.0525%。
公司强调已严格遵守香港联合交易所有限公司证券上市规则及其他相关法律法规。本次公告由公司秘书高海恩签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.